| ÈÀåǰ ¼ººÐ ¿¬±¸ |
| 1 | ¿ä¾à¼³¸í | ±ä ¼±»óÀÇ 2´ç·ù°¡ ¿¬°áµÈ ´Ù´ç·ùÀÌ´Ù. ÁøÇÇÀÇ ¼¼Æ÷¿Ü±âÁú¿¡ ºÐÆ÷ÇÑ´Ù. 4groupÀÌ ÀÖ´Ù. Heparin/heparan sulfate chondroitin sulfate/dermatan sulfate Keratan sulfate hyaluronic acid GAGs are classified into four groups based on core disaccharide structures.[5] Heparin/heparan sulfate (HSGAGs) and chondroitin sulfate/dermatan sulfate (CSGAGs) are synthesized in the Golgi apparatus, where protein cores made in the rough endoplasmic reticulum are post-translationally modified with O-linked glycosylations by glycosyltransferases forming proteoglycans. Keratan sulfate may modify core proteins through N-linked glycosylation or O-linked glycosylation of the proteoglycan. The fourth class of GAG, hyaluronic acid is synthesized by integral membrane synthases which immediately secrete the dynamically elongated disaccharide chain. (ÂüÁ¶) https://en.wikipedia.org/wiki/Glycosaminoglycan
|
||
| 2 | INCI | |||
| 3 | ÇѱÛÀü¼ººÐ¸í | |||
| 4 | µ¿ÀǾî | GAGs, mucopolysaccharides | ||
| 5 | ¹°¸®ÈÇÐÀû Ư¡ | ÈÇÐ½Ä | ||
| ±¸Á¶½Ä |
![]()
|
|||
| ºÐÀÚ·® | ||||
| ½Ç¿ÂÇü»ó | ||||
| ²ú´ÂÁ¡ | ||||
| ³ì´ÂÁ¡ | ||||
| ¿ë¸Å | ||||
| 6 | ¿ø·á Á¤º¸ | ¿ø·á °ø±Þ»ç | ||
| kg´ç °¡°Ý | ||||
| ÁÖ»ç¿ë ³óµµ | ||||
| 100g Á¦Ç°´ç ¼ººÐ°¡°Ý | ||||
| 7 | »ý»ê ¹æ½Ä | |||
| 8 | ¼ººÐ¿¡ ´ëÇÑ ¿ª»ç | |||
| 9 | È¿´É | °æ±¸º¹¿ëÈ¿´É | ||
| ±¹¼ÒµµÆ÷ È¿´É | ||||
| 10 | ÈÀåǰ³» ±â´É
ÁÖ±â´É¡Ü ºÎ±â´É¡Û |
¿ëÁ¦ | ||
| °è¸éȰ¼ºÁ¦ | ||||
| ¹ß¸²¼ºÁ¦ | ||||
| Á¡ÁõÁ¦ | ||||
| pHÁ¶ÀýÁ¦ | ||||
| ų·¹ÀÌÆÃÁ¦ | ||||
| Çâ | ||||
| ¹æºÎÁ¦ | ||||
| È¿´É¼ººÐ µî | ||||
| 11 |
È¿´É¼ººÐ (DOSPAW-O) ÁÖÈ¿´É¡Ü ºÎÈ¿´É¡Û |
DRY º¸½ÀÁ¦ |
À庮°³¼±Á¦ | |
| ÇÔ½ÀÁ¦ | ||||
| ¹ÐÆóÁ¦ | ||||
|
OILY Ç׿ÀÀÏÁ¦ |
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (5a-reductase inhibitor ¾ïÁ¦Á¦) | |||
| ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (ÇÇÁö¼± ¼¼Æ÷ »ç¸êÁ¦) | ||||
| ÇÇÁöÈíÂøÁ¦ | ||||
| °¢ÁúÁ¦°ÅÁ¦ | ||||
|
SENSITIVE Ç׿°Á¦ |
NFkB ¾ïÁ¦Á¦ | |||
| phospholipase ¾ïÁ¦Á¦ | ||||
| Cycloxygenase ¾ïÁ¦Á¦ | ||||
| À庮°³¼±Á¦ | ||||
|
PIGMENT »ö¼Ò¾ïÁ¦Á¦ |
tyrosinase ¾ïÁ¦Á¦ | |||
| ¸á¶ó´Ñ À̵¿ ¾ïÁ¦Á¦ | ||||
| °¢ÁúÁ¦°ÅÁ¦ | ||||
|
ACNE ¿©µå¸§¾ïÁ¦Á¦ |
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (5a-reductase inhibitor ¾ïÁ¦Á¦) | |||
| ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (ÇÇÁö¼± ¼¼Æ÷ »ç¸êÁ¦) | ||||
| °¢ÁúÁ¦°ÅÁ¦ | ||||
| Ç×±ÕÁ¦(MIC) | ||||
| Ç׿°Á¦ | ||||
|
WRINKLE ÁÖ¸§¾ïÁ¦Á¦ (Ç¥ÇÇ) |
Ç¥ÇǼ¼Æ÷Áõ½ÄÁ¦ | |||
| Ç¥ÇǼ¼Æ÷ºÐÈÁ¦ | ||||
| À庮±â´É°³¼±Á¦ | ||||
|
WRINKLE ÁÖ¸§¾ïÁ¦Á¦ (ÁøÇÇ) |
¼¶À¯¾Æ¼¼Æ÷Áõ½ÄÁ¦ | |||
| Äݶó°Õ¼¶À¯»ý¼ºÁ¦ | ||||
| ź·Â¼¶À¯»ý¼ºÁ¦ | ||||
| GAGs»ý¼ºÁõ°¡Á¦ | ||||
| Äݶó°Õ¼¶À¯ºÐÇØ°¨¼ÒÁ¦ | ||||
|
OXIDANT Ç×»êÈÁ¦ |
Ç×»êÈÁ¦ | |||
| 12 | ¿ÏÁ¦Ç° Á¤º¸ | ÁÖ¿ä ÇÔÀ¯ Á¦Ç° | ||
| ´ÚÅÍ¿À¶óŬ Á¦Ç° | ||||
| 13 | °á·Ð | |||
| 14 | Àοë³í¹® | |||